Antide

• Description :

  Antide (D-21074) is a potent LHRH antagonist. Antide also can be used for the research of prostatic cancer[1].

• Product Name Alternative :

  D-21074; ORF 23541

• UNSPSC :

  12352209

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  GnRH Receptor

• Type :

  Peptides

• Related Pathways :

  GPCR/G Protein

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/antide.html

• Purity :

  99.53

• Solubility :

  H2O : 10 mg/mL (ultrasonic)

• Smiles :

  C[C@H](C(N)=O)NC([C@H]1N(C([C@H](CCCCNC(C)C)NC([C@H](CC(C)C)NC([C@@H](CCCCNC(C2=CC=CN=C2)=O)NC([C@H](CCCCNC(C3=CC=CN=C3)=O)NC([C@H](CO)NC([C@@H](CC4=CC=CN=C4)NC([C@@H](CC5=CC=C(Cl)C=C5)NC([C@@H](CC6=CC=C7C=CC=CC7=C6)NC(C)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC1)=O

• Molecular Formula :

  C82H108ClN17O14

• Molecular Weight :

  1591.29

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]U F Habenicht, et al. Effect of the new potent LHRH antagonist antide. J Steroid Biochem Mol Biol. 1990 Dec 20;37 (6) :937-42.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Peptides

• Clinical Information :

  Phase 2

• CAS Number :

  [112568-12-4]